Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.

The effects of dobutamine ([+/-]-4-[2-[[3-(p-hydroxyphenyl)-1-methyl propyl] amino] ethyl] pyrocatechol hydrochloride), a new synthetic cardioactive sympathomimetic amine, were examined on direct and continuous measurements of left ventricular (LV) diameter (D), pressures (P), velocity of shortening (V), dP/dt, dP/dt/P, arterial pressure, cardiac output, and regional blood flows in the left circumflex coronary, mesenteric, renal, and iliac beds in healthy, conscious dogs. At the highest dose of dobutamine examined, 40 mug/kg/min, the drug increased dP/dt/P from 65+/-3 to 128+/-4 s(-1) and isolength velocity from 72+/-4 to 120+/-7 mm/s without affecting LV end diastolic D significantly. Mean arterial P rose from 92+/-2 to 104+/-3 mm Hg and heart rate from 78+/-3 to 111+/-7 beats/min, while LV end systolic D fell from 24.1+/-1.4 to 19.9+/-1.8 mm, reflecting a rise in stroke volume from 30+/-4 to 42+/-3 ml. Cardiac output rose from 2.41+/-0.23 to 4.35+/-0.28 liter/min, while calculated total peripheral resistance declined from 0.042+/-0.005 to 0.028+/-0.003 mm Hg/ml/min. The greatest increases in flow and decreases in calculated resistance occurred in the iliac and coronary beds, and the least occurred in the renal bed. Propranolol blocked the inotropic and beta(2) dilator responses while vasoconstricting effects mediated by alpha adrenergic stimulation remained in each of the beds studied. When dobutamine was infused after a combination of practolol and phentolamine, dilatation occurred in each of the beds studied. These observations indicate that dobutamine is a potent positive inotropic agent with relatively slight effects on preload, afterload, or heart rate, and thus may be a potentially useful clinical agent. The one property of this drug which is not ideal is its tendency to cause a redistribution of cardiac output favoring the muscular beds at the expense of the kidney and visceral beds.

[1]  D Franklin,et al.  Telemetry of left ventricular diameter and pressure measurements from unrestrained animals. , 1974, Journal of applied physiology.

[2]  C. Higgins,et al.  Effects of Norepinephrine on Coronary Circulation and Left Ventricular Dynamics in the Conscious Dog , 1974, Circulation research.

[3]  P. Libby,et al.  Effect of pharmacologic agents on the function of the ischemic heart. , 1973, The American journal of cardiology.

[4]  C. Higgins,et al.  Coronary and myocardial effects of dopamine in the conscious dog: parasympatholytic augmentation of pressor and inotropic actions. , 1973, The Journal of pharmacology and experimental therapeutics.

[5]  E. Braunwald,et al.  Effects and mechanisms of action of dopamine on regional hemodynamics in the conscious dog. , 1973, The American journal of physiology.

[6]  P. Kezdi,et al.  Hemodynamic effects of adrenergic stimulating and blocking agents in cardiogenic shock and low output state after myocardial infarction. , 1973, The American journal of cardiology.

[7]  R. Falicov,et al.  The effects of dopamine on depressed myocardial function following coronary embolization in the closed-chest dog. , 1972, American heart journal.

[8]  H. Loeb,et al.  Use of Drugs in Cardiogenic Shock due to Acute Myocardial Infarction , 1972, Circulation.

[9]  L. I. Goldberg,et al.  Cardiovascular and renal actions of dopamine: potential clinical applications. , 1972, Pharmacological reviews.

[10]  E. Braunwald,et al.  Effects of cardiac depression and of anesthesia on the myocardial action of a cardiac glycoside. , 1971, The Journal of clinical investigation.

[11]  K. Rosen,et al.  Acute Hemodynamic Effects of Dopamine in Patients with Shock , 1971, Circulation.

[12]  D T Mason,et al.  Assessment of Cardiac Contractility: The Relation Between the Rate of Pressure Rise and Ventricular Pressure During Isovolumic Systole , 1971, Circulation.

[13]  J. Covell,et al.  Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions , 1971, Circulation.

[14]  S. Vatner,et al.  Simultaneous comparison and calibration of the Doppler and electromagnetic flowmeters. , 1970, Journal of applied physiology.

[15]  S. Ayres,et al.  Hemodynamics, coronary blood flow, and myocardial metabolism in coronary shock; response of 1-norepinephrine and isoproterenol. , 1970, The Journal of clinical investigation.

[16]  C. D. Johnson,et al.  Effects of isoproterenol on hemodynamic alterations, myocardial metabolism, and coronary flow in experimental acute myocardial infarction with shock. , 1969, American heart journal.

[17]  R. Talley,et al.  A Hemodynamic Comparison of Dopamine and Isoproterenol in Patients in Shock , 1969, Circulation.

[18]  L. I. Goldberg,et al.  The treatment of cardiogenic shock. VI. The search for an ideal drug. , 1968, American heart journal.

[19]  R. Pietras,et al.  Ineffectiveness of isoproterenol in shock due to acute myocardial infarction. , 1967, JAMA.

[20]  J. Morch,et al.  Hemodynamic Studies in Cardiogenic Shock: Treatment with Isoproterenol and Metaraminol , 1967, Circulation.

[21]  G. W. Snedecor.  STATISTICAL METHODS , 1967 .

[22]  E. Braunwald,et al.  MYOCARDIAL FORCE-VELOCITY RELATIONS STUDIED IN INTACT UNANESTHETIZED MAN. , 1965, The Journal of clinical investigation.

[23]  E. Braunwald,et al.  Paradoxical effects of isoproterenol, nitroglycerin and exercise in conscious dogs with myocardial ischemia. , 1973, Transactions of the Association of American Physicians.

[24]  R. V. Van citters,et al.  Technique for radio telemetry of blood-flow velocity from unrestrained animals. , 1966, The American journal of medical electronics.

[25]  Franklin De,et al.  Technique for radio telemetry of blood-flow velocity from unrestrained animals. , 1966 .